Thomas H. Brannagan
- Neurology top 0.5%
- Peripheral Neuropathies and Disorders 55
- Myasthenia Gravis and Thymoma 23
- Botulinum Toxin and Related Neurological Disorders 12
- Gastroenterology top 1%
- Celiac Disease Research and Management 12
-
- Hereditary Neurological Disorders 35
- Nephrology top 2%
- Genetics top 5%
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 23
-
- Peripheral Nerve Disorders 16
-
- Pain Mechanisms and Treatments 9
Thomas H. Brannagan
111 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Neurology 1.8k
- Gastroenterology 319
- Cellular and Molecular Neuroscience 953
- Nephrology 252
- Genetics 262
Countries citing papers authored by Thomas H. Brannagan
This map shows the geographic impact of Thomas H. Brannagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Brannagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Brannagan more than expected).
Fields of papers citing papers by Thomas H. Brannagan
This network shows the impact of papers produced by Thomas H. Brannagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Brannagan. The network helps show where Thomas H. Brannagan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas H. Brannagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 19 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 20 | |
| 8 | 2021 | 31 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 15 | |
| 11 | Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosisbreakdown → | 2019 | 316 |
| 12 | 2018 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2015 | 6 | |
| 15 | 2015 | 11 | |
| 16 | 2014 | 1 | |
| 17 | 2012 | 14 | |
| 18 | 2008 | 48 | |
| 19 | 2007 | 24 | |
| 20 | 2003 | 46 |
About Thomas H. Brannagan
Thomas H. Brannagan is a scholar working on Neurology, Gastroenterology and Cellular and Molecular Neuroscience, having authored 117 papers that have together received 3.6k indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (55 papers), Hereditary Neurological Disorders (35 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers), Myasthenia Gravis and Thymoma (23 papers), Peripheral Nerve Disorders (16 papers), Botulinum Toxin and Related Neurological Disorders (12 papers), Celiac Disease Research and Management (12 papers) and Pain Mechanisms and Treatments (9 papers). The work is most often cited by research in Neurology (1.8k citations), Gastroenterology (319 citations) and Cellular and Molecular Neuroscience (953 citations). Thomas H. Brannagan has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Norman Latov, Russell L. Chin, Howard W. Sander, Lewis P. Rowland, Dale J. Lange, Arthur P. Hays, Yili Zhou, Armin Alaedini, Douglas E. Gladstone and Keith J. Nagle. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.